Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 961446

Hedgehog signaling pathway status in serous ovarian carcinomas


Karin, Valentina; Slavica, Matea; Škrtić, Anita; Vranić, Semir; Šerman, Ljiljana
Hedgehog signaling pathway status in serous ovarian carcinomas // Modern pathology, 31 (2018), Suppl 2
Vancouver: Springer, 2018. str. 428-429 doi:10.1038/modpathol.2018.11 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 961446 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Hedgehog signaling pathway status in serous ovarian carcinomas

Autori
Karin, Valentina ; Slavica, Matea ; Škrtić, Anita ; Vranić, Semir ; Šerman, Ljiljana

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Modern pathology, 31 (2018), Suppl 2 / - Vancouver : Springer, 2018, 428-429

Skup
USCAP 107th Annual Meeting

Mjesto i datum
Vancouver, Kanada, 17.03.2018. - 23.03.2018

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
ovarian carcinoma ; serous ovarian carcinoma ; Hedgehog signaling pathway ; PTCH1 ; GLI1 ; GLI3

Sažetak
Background: Hedgehog (Hh) signaling pathway is a highly conserved signaling pathway involved in cell proliferation and differentiation as well in cell polarity in early embryogenesis and morphogenesis. In adults, it is usually inactive while its hyperactivation is associated with carcinogenesis. Hh signaling pathway is activated via binding of the Hh ligands with PTCH transmembrane protein resulting in increased activity of the GLI transcription factors that subsequently activate targeted genes. PTCH1 acts as a tumor suppressor while GLI1 and GLI3 factors have the opposite transcription activities (former has activating and later mainly inhibiting activity). Design: Formalin-fixed paraffin- embedded samples of 52 ovarian serous carcinomas (low-grade [LGSC, n=11] and high-grade [HGSC, n=41]) were explored for PTCH1, GLI1 and GLI3 expression using immunohistochemistry. PTCH1 DNA methylation status was assessed using methylation- specific PCR assay (MSP). Five normal/benign ovarian tissues served as controls. Results: PTCH1 nuclear expression was significantly higher in both LGSC and HGSC compared with normal/benign ovarian tissue (p<0.001 and p<0.001, respectively) while cytoplasmic PTCH1 protein expression was significantly higher in normal ovaries compared with both LGSC and HGSC (p=0.003 and p<0.001, respectively). PTCH1 DNA methylation was exclusively observed in HGSC (6/41, 15%). GLI1 protein expression was significantly higher in HGSC compared with normal ovaries (p=0.032) while GLI3 protein exhibited significantly higher expression in both LGSC and HGSC in comparison with normal ovaries (p<0.001 and p<0.001, respectively). Notably, GLI3 protein had a higher expression in LGSC compared with HGSC (p=0.043). Conclusion: Hedgehog signaling pathway components PTCH1, GLI1 and GLI3 appear to be actively involved in pathogenesis of serous ovarian carcinomas. A significant proportion of serous ovarian carcinomas exhibits aberrant (nuclear) PTCH1 protein expression. Therefore, PTCH1 may play an active transcriptional role in LGSC and HGSC. A subset of HGSC may have PTCH1 gene deregulation caused by its promoter methylation. Further studies involving more samples should confirm these findings and their clinical relevance.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Karin, Valentina; Slavica, Matea; Škrtić, Anita; Vranić, Semir; Šerman, Ljiljana
Hedgehog signaling pathway status in serous ovarian carcinomas // Modern pathology, 31 (2018), Suppl 2
Vancouver: Springer, 2018. str. 428-429 doi:10.1038/modpathol.2018.11 (poster, međunarodna recenzija, sažetak, znanstveni)
Karin, V., Slavica, M., Škrtić, A., Vranić, S. & Šerman, L. (2018) Hedgehog signaling pathway status in serous ovarian carcinomas. U: Modern pathology, 31 (2018), Suppl 2 doi:10.1038/modpathol.2018.11.
@article{article, author = {Karin, Valentina and Slavica, Matea and \v{S}krti\'{c}, Anita and Vrani\'{c}, Semir and \v{S}erman, Ljiljana}, year = {2018}, pages = {428-429}, DOI = {10.1038/modpathol.2018.11}, keywords = {ovarian carcinoma, serous ovarian carcinoma, Hedgehog signaling pathway, PTCH1, GLI1, GLI3}, doi = {10.1038/modpathol.2018.11}, title = {Hedgehog signaling pathway status in serous ovarian carcinomas}, keyword = {ovarian carcinoma, serous ovarian carcinoma, Hedgehog signaling pathway, PTCH1, GLI1, GLI3}, publisher = {Springer}, publisherplace = {Vancouver, Kanada} }
@article{article, author = {Karin, Valentina and Slavica, Matea and \v{S}krti\'{c}, Anita and Vrani\'{c}, Semir and \v{S}erman, Ljiljana}, year = {2018}, pages = {428-429}, DOI = {10.1038/modpathol.2018.11}, keywords = {ovarian carcinoma, serous ovarian carcinoma, Hedgehog signaling pathway, PTCH1, GLI1, GLI3}, doi = {10.1038/modpathol.2018.11}, title = {Hedgehog signaling pathway status in serous ovarian carcinomas}, keyword = {ovarian carcinoma, serous ovarian carcinoma, Hedgehog signaling pathway, PTCH1, GLI1, GLI3}, publisher = {Springer}, publisherplace = {Vancouver, Kanada} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font